HEADER CELL CYCLE 01-DEC-22 8HLT TITLE THE CO-CRYSTAL STRUCTURE OF DYRK2 WITH YK-2-99B COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE COMPND 3 2; COMPND 4 CHAIN: A, B; COMPND 5 EC: 2.7.12.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DYRK2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, CELL CYCLE EXPDTA X-RAY DIFFRACTION AUTHOR H.T.SHEN,Y.B.XIAO,K.YUAN,P.YANG,Q.N.LI REVDAT 1 13-DEC-23 8HLT 0 JRNL AUTH K.YUAN,H.SHEN,M.ZHENG,F.XIA,Q.LI,W.CHEN,M.JI,H.YANG, JRNL AUTH 2 X.ZHUANG,Z.CAI,W.MIN,X.WANG,Y.XIAO,P.YANG JRNL TITL DISCOVERY OF POTENT DYRK2 INHIBITORS WITH HIGH SELECTIVITY, JRNL TITL 2 GREAT SOLUBILITY, AND EXCELLENT SAFETY PROPERTIES FOR THE JRNL TITL 3 TREATMENT OF PROSTATE CANCER. JRNL REF J.MED.CHEM. V. 66 4215 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 36800260 JRNL DOI 10.1021/ACS.JMEDCHEM.3C00106 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 19.0 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.85 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 27702 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.710 REMARK 3 FREE R VALUE TEST SET COUNT : 1860 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.8500 - 6.5800 0.98 2037 150 0.1915 0.2349 REMARK 3 2 6.5800 - 5.2200 1.00 2033 148 0.2125 0.2523 REMARK 3 3 5.2200 - 4.5600 1.00 2007 142 0.1761 0.2368 REMARK 3 4 4.5600 - 4.1500 1.00 1977 152 0.1823 0.2540 REMARK 3 5 4.1500 - 3.8500 1.00 1978 140 0.2078 0.2748 REMARK 3 6 3.8500 - 3.6200 1.00 1996 143 0.2218 0.2837 REMARK 3 7 3.6200 - 3.4400 1.00 1981 148 0.2198 0.2834 REMARK 3 8 3.4400 - 3.2900 1.00 1980 135 0.2228 0.3106 REMARK 3 9 3.2900 - 3.1700 1.00 1969 144 0.2454 0.3171 REMARK 3 10 3.1700 - 3.0600 1.00 1973 141 0.2538 0.3051 REMARK 3 11 3.0600 - 2.9600 1.00 1972 146 0.2531 0.2828 REMARK 3 12 2.9600 - 2.8800 1.00 1916 137 0.2758 0.3335 REMARK 3 13 2.8800 - 2.8000 1.00 2023 134 0.3091 0.3714 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.360 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.080 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 6460 REMARK 3 ANGLE : 1.255 8710 REMARK 3 CHIRALITY : 0.065 900 REMARK 3 PLANARITY : 0.011 1124 REMARK 3 DIHEDRAL : 15.509 2456 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -17.4588 -11.7727 31.4546 REMARK 3 T TENSOR REMARK 3 T11: 0.5654 T22: 0.4255 REMARK 3 T33: 0.6418 T12: 0.0911 REMARK 3 T13: 0.1476 T23: -0.0406 REMARK 3 L TENSOR REMARK 3 L11: 3.4139 L22: 0.6713 REMARK 3 L33: 0.9963 L12: -0.1020 REMARK 3 L13: 0.9498 L23: -0.3076 REMARK 3 S TENSOR REMARK 3 S11: 0.0137 S12: -0.5422 S13: 0.2584 REMARK 3 S21: 0.0639 S22: -0.0123 S23: 0.1291 REMARK 3 S31: -0.0611 S32: -0.1490 S33: -0.0121 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8HLT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-DEC-22. REMARK 100 THE DEPOSITION ID IS D_1300033858. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-JUL-22 REMARK 200 TEMPERATURE (KELVIN) : 289.15 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL18U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29520 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.740 REMARK 200 RESOLUTION RANGE LOW (A) : 47.850 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.12200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.74 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.81 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 7.00 REMARK 200 R MERGE FOR SHELL (I) : 1.01700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05M HEPES PH7.0, 12%PEG 3350, 1% REMARK 280 TRPTONE, 1MM NAN3, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 289.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 64.91000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.33500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 64.91000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 30.33500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 72 REMARK 465 MET A 73 REMARK 465 GLY A 74 REMARK 465 LYS A 75 REMARK 465 VAL A 76 REMARK 465 LYS A 77 REMARK 465 ARG A 463 REMARK 465 ARG A 464 REMARK 465 GLY B 72 REMARK 465 MET B 73 REMARK 465 GLY B 74 REMARK 465 LYS B 75 REMARK 465 VAL B 76 REMARK 465 LYS B 77 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH1 ARG A 408 CE1 TYR B 346 0.87 REMARK 500 NH1 ARG A 408 CZ TYR B 346 1.78 REMARK 500 CZ ARG A 408 CE1 TYR B 346 1.90 REMARK 500 OD1 ASP B 437 NE2 HIS B 459 2.10 REMARK 500 NH1 ARG A 408 CD1 TYR B 346 2.13 REMARK 500 O GLN A 370 OD1 ASP A 374 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 132 -162.57 -77.60 REMARK 500 ARG A 148 -40.08 -136.08 REMARK 500 ASP A 204 40.19 -90.73 REMARK 500 ASP A 275 45.93 -149.36 REMARK 500 ASP A 295 74.99 42.45 REMARK 500 GLN A 311 164.17 71.16 REMARK 500 ARG A 378 41.56 -84.33 REMARK 500 LYS A 380 27.02 -79.29 REMARK 500 ASP B 132 -165.41 -72.01 REMARK 500 ARG B 148 -37.35 -130.87 REMARK 500 SER B 232 -159.60 -94.35 REMARK 500 CYS B 274 -4.12 72.51 REMARK 500 ASP B 275 52.91 -143.94 REMARK 500 VAL B 306 -52.06 -123.28 REMARK 500 GLN B 311 156.43 73.66 REMARK 500 LYS B 380 27.39 -79.15 REMARK 500 ASP B 399 32.33 -91.48 REMARK 500 ARG B 463 170.01 -51.49 REMARK 500 REMARK 500 REMARK: NULL DBREF 8HLT A 72 464 UNP Q92630 DYRK2_HUMAN 145 537 DBREF 8HLT B 72 464 UNP Q92630 DYRK2_HUMAN 145 537 SEQRES 1 A 393 GLY MET GLY LYS VAL LYS ALA THR PRO MET THR PRO GLU SEQRES 2 A 393 GLN ALA MET LYS GLN TYR MET GLN LYS LEU THR ALA PHE SEQRES 3 A 393 GLU HIS HIS GLU ILE PHE SER TYR PRO GLU ILE TYR PHE SEQRES 4 A 393 LEU GLY LEU ASN ALA LYS LYS ARG GLN GLY MET THR GLY SEQRES 5 A 393 GLY PRO ASN ASN GLY GLY TYR ASP ASP ASP GLN GLY SER SEQRES 6 A 393 TYR VAL GLN VAL PRO HIS ASP HIS VAL ALA TYR ARG TYR SEQRES 7 A 393 GLU VAL LEU LYS VAL ILE GLY LYS GLY SER PHE GLY GLN SEQRES 8 A 393 VAL VAL LYS ALA TYR ASP HIS LYS VAL HIS GLN HIS VAL SEQRES 9 A 393 ALA LEU LYS MET VAL ARG ASN GLU LYS ARG PHE HIS ARG SEQRES 10 A 393 GLN ALA ALA GLU GLU ILE ARG ILE LEU GLU HIS LEU ARG SEQRES 11 A 393 LYS GLN ASP LYS ASP ASN THR MET ASN VAL ILE HIS MET SEQRES 12 A 393 LEU GLU ASN PHE THR PHE ARG ASN HIS ILE CYS MET THR SEQRES 13 A 393 PHE GLU LEU LEU SER MET ASN LEU TYR GLU LEU ILE LYS SEQRES 14 A 393 LYS ASN LYS PHE GLN GLY PHE SER LEU PRO LEU VAL ARG SEQRES 15 A 393 LYS PHE ALA HIS SER ILE LEU GLN CYS LEU ASP ALA LEU SEQRES 16 A 393 HIS LYS ASN ARG ILE ILE HIS CYS ASP LEU LYS PRO GLU SEQRES 17 A 393 ASN ILE LEU LEU LYS GLN GLN GLY ARG SER GLY ILE LYS SEQRES 18 A 393 VAL ILE ASP PHE GLY SER SER CYS TYR GLU HIS GLN ARG SEQRES 19 A 393 VAL TYR THR PTR ILE GLN SER ARG PHE TYR ARG ALA PRO SEQRES 20 A 393 GLU VAL ILE LEU GLY ALA ARG TYR GLY MET PRO ILE ASP SEQRES 21 A 393 MET TRP SER LEU GLY CYS ILE LEU ALA GLU LEU LEU THR SEQRES 22 A 393 GLY TYR PRO LEU LEU PRO GLY GLU ASP GLU GLY ASP GLN SEQRES 23 A 393 LEU ALA CYS MET ILE GLU LEU LEU GLY MET PRO SER GLN SEQRES 24 A 393 LYS LEU LEU ASP ALA SER LYS ARG ALA LYS ASN PHE VAL SEQRES 25 A 393 SER SER LYS GLY TYR PRO ARG TYR CYS THR VAL THR THR SEQRES 26 A 393 LEU SER ASP GLY SER VAL VAL LEU ASN GLY GLY ARG SER SEQRES 27 A 393 ARG ARG GLY LYS LEU ARG GLY PRO PRO GLU SER ARG GLU SEQRES 28 A 393 TRP GLY ASN ALA LEU LYS GLY CYS ASP ASP PRO LEU PHE SEQRES 29 A 393 LEU ASP PHE LEU LYS GLN CYS LEU GLU TRP ASP PRO ALA SEQRES 30 A 393 VAL ARG MET THR PRO GLY GLN ALA LEU ARG HIS PRO TRP SEQRES 31 A 393 LEU ARG ARG SEQRES 1 B 393 GLY MET GLY LYS VAL LYS ALA THR PRO MET THR PRO GLU SEQRES 2 B 393 GLN ALA MET LYS GLN TYR MET GLN LYS LEU THR ALA PHE SEQRES 3 B 393 GLU HIS HIS GLU ILE PHE SER TYR PRO GLU ILE TYR PHE SEQRES 4 B 393 LEU GLY LEU ASN ALA LYS LYS ARG GLN GLY MET THR GLY SEQRES 5 B 393 GLY PRO ASN ASN GLY GLY TYR ASP ASP ASP GLN GLY SER SEQRES 6 B 393 TYR VAL GLN VAL PRO HIS ASP HIS VAL ALA TYR ARG TYR SEQRES 7 B 393 GLU VAL LEU LYS VAL ILE GLY LYS GLY SER PHE GLY GLN SEQRES 8 B 393 VAL VAL LYS ALA TYR ASP HIS LYS VAL HIS GLN HIS VAL SEQRES 9 B 393 ALA LEU LYS MET VAL ARG ASN GLU LYS ARG PHE HIS ARG SEQRES 10 B 393 GLN ALA ALA GLU GLU ILE ARG ILE LEU GLU HIS LEU ARG SEQRES 11 B 393 LYS GLN ASP LYS ASP ASN THR MET ASN VAL ILE HIS MET SEQRES 12 B 393 LEU GLU ASN PHE THR PHE ARG ASN HIS ILE CYS MET THR SEQRES 13 B 393 PHE GLU LEU LEU SER MET ASN LEU TYR GLU LEU ILE LYS SEQRES 14 B 393 LYS ASN LYS PHE GLN GLY PHE SER LEU PRO LEU VAL ARG SEQRES 15 B 393 LYS PHE ALA HIS SER ILE LEU GLN CYS LEU ASP ALA LEU SEQRES 16 B 393 HIS LYS ASN ARG ILE ILE HIS CYS ASP LEU LYS PRO GLU SEQRES 17 B 393 ASN ILE LEU LEU LYS GLN GLN GLY ARG SER GLY ILE LYS SEQRES 18 B 393 VAL ILE ASP PHE GLY SER SER CYS TYR GLU HIS GLN ARG SEQRES 19 B 393 VAL TYR THR PTR ILE GLN SER ARG PHE TYR ARG ALA PRO SEQRES 20 B 393 GLU VAL ILE LEU GLY ALA ARG TYR GLY MET PRO ILE ASP SEQRES 21 B 393 MET TRP SER LEU GLY CYS ILE LEU ALA GLU LEU LEU THR SEQRES 22 B 393 GLY TYR PRO LEU LEU PRO GLY GLU ASP GLU GLY ASP GLN SEQRES 23 B 393 LEU ALA CYS MET ILE GLU LEU LEU GLY MET PRO SER GLN SEQRES 24 B 393 LYS LEU LEU ASP ALA SER LYS ARG ALA LYS ASN PHE VAL SEQRES 25 B 393 SER SER LYS GLY TYR PRO ARG TYR CYS THR VAL THR THR SEQRES 26 B 393 LEU SER ASP GLY SER VAL VAL LEU ASN GLY GLY ARG SER SEQRES 27 B 393 ARG ARG GLY LYS LEU ARG GLY PRO PRO GLU SER ARG GLU SEQRES 28 B 393 TRP GLY ASN ALA LEU LYS GLY CYS ASP ASP PRO LEU PHE SEQRES 29 B 393 LEU ASP PHE LEU LYS GLN CYS LEU GLU TRP ASP PRO ALA SEQRES 30 B 393 VAL ARG MET THR PRO GLY GLN ALA LEU ARG HIS PRO TRP SEQRES 31 B 393 LEU ARG ARG MODRES 8HLT PTR A 309 TYR MODIFIED RESIDUE MODRES 8HLT PTR B 309 TYR MODIFIED RESIDUE HET PTR A 309 16 HET PTR B 309 16 HET XSE A 501 49 HET XSE B 501 49 HETNAM PTR O-PHOSPHOTYROSINE HETNAM XSE (6-{[(4P)-4-(1,3-BENZOTHIAZOL-5-YL)-5-FLUOROPYRIMIDIN- HETNAM 2 XSE 2-YL]AMINO}PYRIDIN-3-YL)(PIPERAZIN-1-YL)METHANONE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 3 XSE 2(C21 H18 F N7 O S) HELIX 1 AA1 THR A 82 MET A 91 1 10 HELIX 2 AA2 GLN A 92 LEU A 94 5 3 HELIX 3 AA3 THR A 95 ILE A 102 1 8 HELIX 4 AA4 PHE A 103 TYR A 105 5 3 HELIX 5 AA5 GLY A 124 GLY A 129 1 6 HELIX 6 AA6 GLU A 183 LYS A 202 1 20 HELIX 7 AA7 ASN A 234 ASN A 242 1 9 HELIX 8 AA8 SER A 248 ASN A 269 1 22 HELIX 9 AA9 LYS A 277 GLU A 279 5 3 HELIX 10 AB1 ASP A 295 SER A 299 5 5 HELIX 11 AB2 SER A 312 ARG A 316 5 5 HELIX 12 AB3 ALA A 317 GLY A 323 1 7 HELIX 13 AB4 MET A 328 GLY A 345 1 18 HELIX 14 AB5 ASP A 353 GLY A 366 1 14 HELIX 15 AB6 SER A 369 ALA A 375 1 7 HELIX 16 AB7 ARG A 378 VAL A 383 1 6 HELIX 17 AB8 GLU A 422 LEU A 427 1 6 HELIX 18 AB9 ASP A 432 LEU A 443 1 12 HELIX 19 AC1 THR A 452 ARG A 458 1 7 HELIX 20 AC2 THR B 82 MET B 91 1 10 HELIX 21 AC3 GLN B 92 LEU B 94 5 3 HELIX 22 AC4 THR B 95 ILE B 102 1 8 HELIX 23 AC5 PHE B 103 TYR B 105 5 3 HELIX 24 AC6 GLY B 124 GLY B 129 1 6 HELIX 25 AC7 GLU B 183 ARG B 201 1 19 HELIX 26 AC8 ASN B 234 ASN B 242 1 9 HELIX 27 AC9 SER B 248 ASN B 269 1 22 HELIX 28 AD1 LYS B 277 GLU B 279 5 3 HELIX 29 AD2 ASP B 295 SER B 299 5 5 HELIX 30 AD3 SER B 312 ARG B 316 5 5 HELIX 31 AD4 ALA B 317 GLY B 323 1 7 HELIX 32 AD5 MET B 328 GLY B 345 1 18 HELIX 33 AD6 ASP B 353 GLY B 366 1 14 HELIX 34 AD7 SER B 369 ALA B 375 1 7 HELIX 35 AD8 SER B 376 PHE B 382 5 7 HELIX 36 AD9 GLU B 422 LEU B 427 1 6 HELIX 37 AE1 ASP B 432 LEU B 443 1 12 HELIX 38 AE2 THR B 452 HIS B 459 1 8 SHEET 1 AA1 6 HIS A 144 VAL A 145 0 SHEET 2 AA1 6 TYR A 149 GLY A 158 -1 O TYR A 149 N VAL A 145 SHEET 3 AA1 6 GLY A 161 ASP A 168 -1 O VAL A 163 N GLY A 156 SHEET 4 AA1 6 GLN A 173 VAL A 180 -1 O GLN A 173 N ASP A 168 SHEET 5 AA1 6 HIS A 223 GLU A 229 -1 O MET A 226 N LYS A 178 SHEET 6 AA1 6 MET A 214 PHE A 220 -1 N LEU A 215 O THR A 227 SHEET 1 AA2 2 ILE A 271 ILE A 272 0 SHEET 2 AA2 2 CYS A 300 TYR A 301 -1 O CYS A 300 N ILE A 272 SHEET 1 AA3 2 ILE A 281 LEU A 283 0 SHEET 2 AA3 2 ILE A 291 VAL A 293 -1 O LYS A 292 N LEU A 282 SHEET 1 AA4 2 THR A 393 THR A 396 0 SHEET 2 AA4 2 VAL A 402 ASN A 405 -1 O ASN A 405 N THR A 393 SHEET 1 AA5 2 GLY A 407 ARG A 408 0 SHEET 2 AA5 2 LEU A 414 ARG A 415 -1 O ARG A 415 N GLY A 407 SHEET 1 AA6 6 HIS B 144 VAL B 145 0 SHEET 2 AA6 6 TYR B 149 GLY B 158 -1 O TYR B 149 N VAL B 145 SHEET 3 AA6 6 GLY B 161 ASP B 168 -1 O LYS B 165 N LYS B 153 SHEET 4 AA6 6 GLN B 173 VAL B 180 -1 O GLN B 173 N ASP B 168 SHEET 5 AA6 6 HIS B 223 GLU B 229 -1 O PHE B 228 N ALA B 176 SHEET 6 AA6 6 MET B 214 PHE B 220 -1 N LEU B 215 O THR B 227 SHEET 1 AA7 2 ILE B 271 ILE B 272 0 SHEET 2 AA7 2 CYS B 300 TYR B 301 -1 O CYS B 300 N ILE B 272 SHEET 1 AA8 2 ILE B 281 LEU B 283 0 SHEET 2 AA8 2 ILE B 291 VAL B 293 -1 O LYS B 292 N LEU B 282 SHEET 1 AA9 2 THR B 393 THR B 396 0 SHEET 2 AA9 2 VAL B 402 ASN B 405 -1 O ASN B 405 N THR B 393 SHEET 1 AB1 2 GLY B 407 ARG B 408 0 SHEET 2 AB1 2 LEU B 414 ARG B 415 -1 O ARG B 415 N GLY B 407 LINK C THR A 308 N PTR A 309 1555 1555 1.34 LINK C PTR A 309 N ILE A 310 1555 1555 1.33 LINK O2P PTR A 309 NH1 ARG A 313 1555 1555 1.31 LINK C THR B 308 N PTR B 309 1555 1555 1.33 LINK C PTR B 309 N ILE B 310 1555 1555 1.33 CRYST1 129.820 60.670 155.340 90.00 113.08 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007703 0.000000 0.003282 0.00000 SCALE2 0.000000 0.016483 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006998 0.00000